Skip to main content

Advertisement

SpringerLink
Log in

Treatment for multiple bilobar liver metastases of colorectal cancer

  • New Surgical Horizons
  • Published:
Langenbeck's Archives of Surgery Aims and scope Submit manuscript

Abstract

Background

Recent advances have extended indications for hepatectomy to include multiple bilobar colorectal liver metastases (CLM). Staging systems based on the biological malignancy of primary and metastatic tumors provide appropriate indications for hepatectomy in CLM. However, suitability for resection in patients with complex and extensive hepatic metastases is controversial.

Methods

A medline search was performed to identify papers reporting the resection for CLM. Techniques, indication, and results were reviewed.

Results

If the anticipated remnant liver volume is small (25–40% of total), suggesting a high risk of postoperative liver failure, portal vein embolization (PVE) is recommended prior to hepatectomy. However, curative resections are not always possible. Specifically in synchronous multiple bilobar CLM, two-stage hepatectomy, comprising bilateral hepatectomy and primary resection with or without PVE, can prevent growth of ipsilateral metastatic nodules in the remnant liver and reduce surgical risk. Several local ablation techniques can complement surgery if hepatic resection alone increases the risk of postoperative liver failure or is not curative. Chemotherapy combined with targeted treatment can suppress recurrence and extend indications for hepatectomy by reducing the size and number of primary irresectable tumors.

Conclusion

PVE or staged procedure combining with local ablation or neoadjuvant, downstaging or adjuvant therapies extends indications for hepatectomy to include multiple bilobar CLM. The 5-year survival rate for multiple bilobar CLM treated with alternating hepatectomy and chemotherapy is comparable to the values reported for single and hemilateral CLM.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Jaeck D, Bachellier P, Guiguet M, Boudjema K, Vaillant JC, Balladur P, Nordlinger B (1997) Long-term survival following resection of colorectal hepatic metastases: Association Francaise de Chirurugie. Br J Surg 84:977–980

    PubMed  CAS  Google Scholar 

  2. Nordlinger B, Guiguet M, Vaillant JC, Balladur P, Boudjema K, Bachellier P, Jaeck D (1996) Surgical resection of colorectal carcinoma metastases to the liver: a prognostic scoring system to improve case selection based on 1568 patients. Cancer 77:1254–1262

    Article  PubMed  CAS  Google Scholar 

  3. Gayowski TJ, Iwatsuki S, Madariaga JR, Selby R, Todo S, Irish W, Starzl TE (1994) Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathological risk factors. Surgery 116:703–711

    PubMed  CAS  Google Scholar 

  4. Registry of Hepatic Metastases (1988) Resection of the liver for colorectal carcinoma metastases: multi-institutional study of indications for resection. Surgery 103:278–288

    Google Scholar 

  5. Minagawa M, Makuuchi M, Torzilli G, Takayama, Kawasaki S, Kosuge T, Yamamoto J, Imamura H (2000) Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long term results. Ann Surg 231:487–499

    Article  PubMed  CAS  Google Scholar 

  6. Fong Y, Cohen AM, Fortner JG, Enker WE, Turnbull AD, Coit DG, Marrero AM, Prasad M, Blumgart LH, Brennan MF (1997) Liver resection for colorectal metastases. J Clin Oncol 15:938–946

    PubMed  CAS  Google Scholar 

  7. Scheele J, Stangl R, Altendorf-Hofmann A, Grube T, Hohenberger W, Stangl R, Schmidt K (1995) Resection of colorectal metastases. World J Surg 19:59–71

    Article  PubMed  CAS  Google Scholar 

  8. Ueno H, Mochizuki H, Hatsuse K, Hase K, Yamamoto T (2000) Indications for treatment strategies of colorectal liver metastases. Ann Surg 231:59–66

    Article  PubMed  CAS  Google Scholar 

  9. Shimada H, Tanaka K, Masui H, Nagano Y, Matsuo K, Kijima M, Ichikawa Y, Ike H, Ooki S, Togo S (2004) Result of surgical treatment for multiple (>5 nodules) bilobar-hepatic metastases from colorectal cancer. Langenbecks Arch Surg 389:114–121

    Article  PubMed  Google Scholar 

  10. Tanaka K, Shimada H, Togo S, Ota M, Yamaguchi I, Ike H (2001) Is hepatic resection for multiple liver metastases from colorectal carcinoma acceptable treatment? Hepatogastroenterology 48:803–807

    PubMed  CAS  Google Scholar 

  11. Wood CB, Gillis CR, Blumgardit LH (1976) A retrospective study of the natural history of patients with liver metastases from colorectal cancer. Clin Oncol 2:285–288

    PubMed  CAS  Google Scholar 

  12. Goslin R, Steele G Jr, Zamcheck M, Mayer R, MacIntyre J (1982) Factors influencing survival in patients with hepatic metastases from adenocarcinoma of the colon and rectum. Dis Colon Rectum 25:749–754

    PubMed  CAS  Google Scholar 

  13. Neilsen J, Balslev I, Jensen HE (1971) Carcinoma of the colon with liver metastases: operative indications and prognosis. Acta Chir Scand 137:463–465

    PubMed  Google Scholar 

  14. Haider MA, Amitai MM, Rappaport D, O’Malley ME, Hanbridge AE, Redston M, Lockwood GA, Gallinger S (2002) Multi-detector row CT in preoperative assessment of small (≤1.5 cm) liver metastasis: is thinner collimation better. Radiology 225:137–142

    PubMed  Google Scholar 

  15. Sica GT, Ji H, Ros PR (2002) Computed tomography and magnetic resonance imaging of hepatic metastases. Clin Liver Dis 6:165–179

    Article  PubMed  Google Scholar 

  16. Giovagoni A, Marteganic A, Aiani L et al (2001) Pulse inversion US with echographic contrast media in the evaluation of hepatic metastases. Radiol Med 101:111–117

    Google Scholar 

  17. Esteban JM, Molla MA, Tomas C, Maldonado L (2002) Improved detection of liver metastases with contrast-enhanced wide band harmonic imaging: comparison with CT findings. Eur J Ultrasound 15:119–126

    Article  PubMed  CAS  Google Scholar 

  18. Ruer TJ, Langenhoff BS, Neeleman N, Jager GJ, Strijk S, Wobbes T, Corstens FH, Oyen WJ (2002) Value of positron emission tomography with [F-18]fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study. J Clin Oncol 20:388–395

    Article  PubMed  Google Scholar 

  19. Minagawa M, Makuuchi M, Kubota K, Kondo Y (2004) Intraoperative three dimensional ultrasound visualization of liver vasculature. Hepatogastroenterology 51:1448–1450

    PubMed  Google Scholar 

  20. Yamanaka N, Okamoto E, Kuwata E, Tanaka N (1984) A multiple regression equation for prediction of posthepatectomy liver failure. Ann Surg 200:658–663

    PubMed  CAS  Google Scholar 

  21. Boerma EJ (1990) Research into the results of resection of hilar bile duct cancer. Surgery 108:572–580

    PubMed  CAS  Google Scholar 

  22. Kemeny NE, Kemeny MM, Lawrens TS (2000) Liver metastases. In: Abeloff MD (ed) Clinical oncology. Churchill Livingstone, New York, pp 886–921

    Google Scholar 

  23. Goldberg RM, Sargent DJ, Morton RF, Fuchs CS, Ramanathan RK, Williamson SK, Findlay BP, Pitot HC, Alberts SR (2004) A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 22:23–30

    Article  PubMed  CAS  Google Scholar 

  24. Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W, Berlin J, Baron A, Griffing S, Holmgren E, Ferrera N, Fyfe G, Rogers B, Ross R, Kabbinavar F (2004) Bevacimab plus irinotecan, fluorouracil and leukovorin for metastatic colorectal cancer. N Engl J Med 350:2335–2342

    Article  PubMed  CAS  Google Scholar 

  25. Jaeck D, Oussoultzoglou E, Rosso E, Greget M, Weber J-C, Bachellier P (2004) A two-stage hepatectomy procedure combined with portal vien embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases. Ann Surg 240:1037–1051

    Article  PubMed  Google Scholar 

  26. Adam R, Pascal G, Castaing D, Azouley D, Delvart V, Paule B, Levi F, Bismuth H (2004) Tumor progression while on chemotherapy a contra indication to liver resection for multiple colorectal metastases? Ann Surg 240:1052–1064

    Article  PubMed  Google Scholar 

  27. Johnson K, Bakhsh A, Young D, Martin TE Jr, Arnold M (2001) Correlating computing tomography and positron emission tomography scan with operative findings in metastatic colorectal cancer. Dis Colon Rectum 44(3):354–357

    Article  PubMed  CAS  Google Scholar 

  28. Selzner M, Hany TF, Wildbertt P, Mc Cormack L, Kadry Z, Clavien P (2004) Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver. Ann Surg 240:1026–1027

    Google Scholar 

  29. Kubota K, Makuuchi M, Kusaka K, Kobayashi T, Miki K, Hasegawa K, Harihara Y, Takayama T (1997) Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology 26:1176–1181

    PubMed  CAS  Google Scholar 

  30. Soyer P, Roche A, Elias D, Levesque M (1992) Hepatic metastases from colorectal cancer: influence of hepatic volumetric analysis on surgical decision-making. Radiology 184:695–697

    PubMed  CAS  Google Scholar 

  31. Henderson JM, Heymsfield SB, Horowitz J, Kutner MH (1981) Measurement of liver and spleen volume by computed tomography. Radiology 141:525–527

    PubMed  CAS  Google Scholar 

  32. Penna C, Nordinger B (2002) Colorectal metastasis (liver and 1ung). Surg Clin N Am 82:1075–1090

    Article  PubMed  Google Scholar 

  33. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230:309–321

    Article  PubMed  CAS  Google Scholar 

  34. Bulton JS, Fuhman GM (2000) Survival after resection of multiple bilobar hepatic metastases from colorectal carcinoma. Ann Surg 231:743–751

    Article  PubMed  Google Scholar 

  35. Taylor I (1985) Colorectal liver metastases—to treat or not to treat? Br J Surg 72:511–516

    PubMed  CAS  Google Scholar 

  36. Tanaka K, Shimada H, Fujii Y, Endo I, Sekido H, Togo S, Ike H (2004) Pre-hepatectomy prognostic staging to determine treatment strategy for colorectal cancer metastases to the liver. Langenbecks Arch Surg 389(5):371–379

    Article  PubMed  Google Scholar 

  37. Ueno H, Mochizuki H, Hatsuse K, Hase K, Yamamoto T (2000) Indications for treatment strategies of colorectal liver metastases. Ann Surg 231:59–66

    Article  PubMed  CAS  Google Scholar 

  38. Tanaka K, Shimada H, Miura M, Fujii Y, Yamaguchi S, Endo I, Sekido H, Togo S, Ike H (2004) Metastatic doubling time: the most important predictor of survival and non-recurrence in hepatic colorectal metastasis. World J Surg 28:263–270

    Article  PubMed  Google Scholar 

  39. Fusai G, Davidson BR (2003) Strategies to increase the respectability of liver metastases from colorectal cancer. Dig Surg 20:481–496

    Article  PubMed  CAS  Google Scholar 

  40. Adam R, Delvart V, Pascal G, Valeanu A, Castaing D, Azoulay D, Giacchetti S, Paule B, Kunstlinger F, Ghemard O, Levi F, Bismuth H (2004) Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 240:644–657

    PubMed  Google Scholar 

  41. Bismuth H, Adam R, Levi F, Farabos C, Waechter F, Castaing D, Majno P, Engerran L (1996) Resection of unresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 224:509–520

    Article  PubMed  CAS  Google Scholar 

  42. Imamura H, Kawasaki S (1999) Treatment strategy for multiple hepatic metastases of colorectal carcinoma. J Hepatobiliary Pancreat Surg 6:23–29

    Article  PubMed  CAS  Google Scholar 

  43. Rosen CB, Nagorney DM, Taswell HF, Helgeson SL, Ilstrup DM, van Heerden JA, Adson MA (1992) Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma. Ann Surg 216:493–505

    PubMed  CAS  Google Scholar 

  44. Sugawara Y, Yamamoto J, Yamasaki S, Shimada K, Kosuge T, Makuuchi M (2001) Estimating the prognosis of hepatic resection in patients with metastatic liver tumors from colorectal cancer with special concern for the timing of hepatectomy. Surgery 129:408–413

    PubMed  CAS  Google Scholar 

  45. Elias D, Ouellet JF, Bellon N, Pignon JP, Pocard M, Lasser P (2003) Extra hepatic disease does not contraindicate hepatectomy for colorectal liver metastases. Br J Surg 90:567–574

    Article  PubMed  CAS  Google Scholar 

  46. Pichlmayer R (1988) Is there a place for liver grafting for malignancy. Transplant Proc 20:478–482

    Google Scholar 

  47. Azouley D, Castaing D, Smail A, Adam R, Cally V, Laurent A, Lemoine A, Bismuth H (2000) Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg 231:480–486

    Article  PubMed  Google Scholar 

  48. Makuuchi M, Thai BL, Takayasu K, Takayama T, Kosuge T, Gunnven P, Yamazaki S, Hasegawa H, Ozaki H (1990) Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery 107:521–527

    PubMed  CAS  Google Scholar 

  49. Harada H, Imamura H, Miyagawa S, Kawasaki S (1997) Fate of human liver after hemihepatic portal vein embolization: cell kinetic and morphometric study. Hepatology 26:1162–1170

    PubMed  CAS  Google Scholar 

  50. Kokudo N, Tda K, Seki M, Ohta H, Azekura K, Ueno M, Ohta K, Yamaguchi T, Matsubara T, Nakajima T, Muto T, Ikari T, Yanagisawa A, Kato Y (2001) Proliferative activity of intrahepatic colorectal metastases after preoperative hemi-hepatic portal vein embolization. Hepatology 34:267–272

    Article  PubMed  CAS  Google Scholar 

  51. Fujii Y, Shimada H, Endo I, Kamiyama M, Kamimukai N, Tanaka K et al (2000) Changes in clinicopathological findings after portal vein embolization. Hepatogastroenterology 47:1560–1563

    PubMed  CAS  Google Scholar 

  52. De Baere T, Roche A, Elias D, Lasser P, Lagrange C, Bousson V (1996) Preoperative portal vein embolization for extension of hepatectomy indications. Hepatology 24:1386–1391

    Article  PubMed  Google Scholar 

  53. Adam R, Laurent A, Azouley D, Castaing D, Bismuth H (2000) Two-stage hepatectomy: a planned strategy to treat irresectable liver tumors. Ann Surg 232:777–785

    Article  PubMed  CAS  Google Scholar 

  54. Togo S, Nagano Y, Masui H, Tanaka K, Miura Y, Morita D, Endo I, Sekido H, Ike H, Shimada H (2005) Two-stage hepatectomy for multiple biolobular liver metastases from colorectal cancer. Hepatogastroenterology 52:913–919

    PubMed  Google Scholar 

  55. Bakalakas EA, Kim JA, Young D, Martin EW Jr (1998) Determinants of survival following hepatic resection for metastactic colorectal cancer. World J Surg 22:399–405

    Article  PubMed  Google Scholar 

  56. Ekberg H, Tranberg KG, Andersson R, Lundstedt C, Hagerstrand I, Ranstam J, Bengmark S (1986) Determinants of survival in liver resection for colorectal secondaries. Br J Surg 73:727–731

    PubMed  CAS  Google Scholar 

  57. Cady B, Jenkins RL, Steele GD Jr, Lewis WD, Stone MD, McDermott WV, Jessup JM, Bothe A, Lalor P, Lovett EJ, Lavin P, Linehan DC (1998) Surgical margin in hepatic resection for colorectal metastasis: a critical and improbable determinant of outcome. Ann Surg 227:566–571

    Article  PubMed  CAS  Google Scholar 

  58. Shirabe K, Takenaka K, Gion T, Fujiwara Y, Shimada M, Yanaga K, Maeda T, Kajiyama K, Sugimachi K (1997) Analysis of prognostic risk factors in hepatic resection for metastatic colorectal carcinoma with special reference to the surgical margin. Br J Surg 84:1077–1080

    Article  PubMed  CAS  Google Scholar 

  59. Yasui K, Hirata T, Kato T, Torii A, Uesaka K, Morimoto T, Kodera Y, Yamamura Y, Kito T, Hamajima N (1997) A new macroscopic classification predicts prognosis for patient with liver metastases from colorectal cancer. Ann Surg 266:582–586

    Article  Google Scholar 

  60. Elias D, Caralcanti A, Sabourin JC, Pignon JP, Dureux M, Lasser P (1998) Result of 136 curative hepatectomies with a safety margin of less than 10 mm for colorectal metastases. J Surg Oncol 69:88–93

    Article  PubMed  CAS  Google Scholar 

  61. Nanko M, Shimada H, Yamaoka H, Tanaka K, Masui H, Matsuo K, Ike H, Oki S, Hara M (1998) Micrometastatic colorectal cancer lesion in the liver. Surg Today 28:707–713

    Article  PubMed  CAS  Google Scholar 

  62. Fuhrman GM, Curley SA, Hohn DC, Roh MS (1995) Improved survival after resection of colorectal liver metastases. Ann Surg Oncol 2:537–541

    Article  PubMed  CAS  Google Scholar 

  63. Steele G Jr, Bleday R, Mayer RJ, Lindblad A, Petrelli N, Weaver D (1991) A prospective evaluation of hepatic resection for colorectal carcinoma metastases to the liver: gastrointestinal tumor study group protocol 6584. J Clin Oncol 9:1105–1112

    PubMed  Google Scholar 

  64. Altendorf-Hofmann A, Scheele JA (2003) A critical review of the major indicators of prognosis after resection of hepatic metastases from colorectal carcinoma. Surg Oncol Clin N Am 12:165–192

    Article  PubMed  Google Scholar 

  65. Pawlik TM, Scoggins CR, Zorzi O, Abdalla EK, Andre A, Eng C, Curley SA, Loyer EM, Muratore A, Mentha G, Capussotti L, Vanthey JN (2005) Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 241:715–724

    Article  PubMed  Google Scholar 

  66. Yamamoto J, Sugihara K, Kosuge J, Takayama T, Shimada T, Yamasaki S, Sakamoto M, Hirohashi S (1995) Pathological support for limited hepatectomy in the treatment of liver metastasis from colorectal cancer. Ann Surg 221:74–78

    PubMed  CAS  Google Scholar 

  67. Kokudo N, Miki Y, Sugai S, Yanagisawa A, Kato Y, Sakamoto Y, Yamamoto J, Yamaguchi T, Muto T, Makuuchi M (2002) Genetic and histological assessment of surgical margins in resected liver metastases from colorectal carcinoma: minimum surgical margins for successful resection. Arch Surg 137:833–840

    Article  PubMed  Google Scholar 

  68. Sheele J, Stangle R, Altendorf-Hoffmann A et al (1991) Indications of prognosis after hepatic resection for colorectal secondary. Surgery 110:13–19

    PubMed  Google Scholar 

  69. Rous P, Larimore LD (1920) Relation of the portal flow to liver maintenance. A demonstration of liver atrophy conditional to on compensation. J Exp Med 31:609–632

    Article  Google Scholar 

  70. Abdalla EK, Vauthey J-N, Ellis LM, Ellis V, Pollock R, Broglio KR, Hess K, Curly SA (2004) Recurrence and anticome following hepatic resection, Rf and combined resection/ablation for colorectal liver metastases. Ann Surg 239:818–827

    Article  PubMed  Google Scholar 

  71. de Baere T, Roche A, Elias D, Lasser P, Lagrange C, Bousson V (1996) Preoperative portal vein embolization for extension of hepatectomy indications. Hepatology 24:1386–1391

    Article  PubMed  Google Scholar 

  72. Vauthey JN, Chaoui A, Do KA, Bilimoria MM, Fenstermacher MJ, Charsangavej C, Hicks M, Alsfasser G, Lauwers G, Hawkins IF, Caridi J (2000) Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical association. Surgery 127:512–519

    Article  PubMed  CAS  Google Scholar 

  73. Nagino M, Nimura Y, Kondo S, Kanai M (1996) Selective percutaneous transhepatic embolization of the portal vein in preparation for extensive liver resection: the ipsilateral approach. Radiology 200:559–563

    PubMed  CAS  Google Scholar 

  74. Uesaka K, Nimura Y, Nagino M (1996) Changes in hepatic lobar function after right portal vein embolization. An appraisal by biliary indocyanine green excretion. Ann Surg 223:77–83

    Article  PubMed  CAS  Google Scholar 

  75. Nagtano Y, Nagahori K, Fujii Y, Hamaguchi Y, Ishikawa T, Ichikawa Y, Togo S, Okazaki Y, Hayashizaki Y, Shimada H (2004) Gene expression profile analysis of regenerating liver after portal vein ligation in rats by a cDNA microarray system. Liver Int 24:253–258

    Article  PubMed  CAS  Google Scholar 

  76. Elics D, De Baare T, Roche A, Ducreaux M, Leclere J, Lasser P (1999) During liver regeneration following right portal embolization, the growth rate of liver metastases is more rapid than that of the liver parenchyma. Br J Surg 86:784–788

    Article  PubMed  Google Scholar 

  77. Kianmanesh R, Farges O, Abdalla EK, Sauvanet A, Ruszniewski P, Belghiti J (2003) Right portal vein ligation: a new planned two-step all surgical approach for complete resection of primary gastrointestinal tumors with multiple bilateral liver metastases. J Am Coll Surg 197:164–170

    Article  PubMed  Google Scholar 

  78. Petrowski H, Goren M, Janargen W, Loreng M, Dematteo R, Heinrich S, Encke A, Blumgart L, Fong Y (2002) Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer. Ann Surg 235:863–871

    Article  PubMed  Google Scholar 

  79. Shibata T, Niinobu T, Ogata N, Takami M (2000) Microwave coagulation therapy for multiple hepatic metastases from colorectal carcinoma. Cancer 89:276–284

    Article  PubMed  CAS  Google Scholar 

  80. Morita T, Shibata T, Okuyama M, Ikeda K, Takahara Y, Kitada M, Takashi S (2004) Microwave coagulation therapy for liver metastases from colorectal cancer. Jpn J Cancer Chemother 31(5):695–699

    Google Scholar 

  81. Ruers TJ, Josten J, Jager GJ, Wobbes T (2001) Long-term results of treating hepatic colorectal metastases with cryotherapy. Br J Surg 88:844–849

    Article  PubMed  CAS  Google Scholar 

  82. Grothey A, Schmoll HJ (2001) New chemotherapy approaches in colorectal cancer. Curr Opin Oncol 13:275–286

    Article  PubMed  CAS  Google Scholar 

  83. Masi G, Allegrini G, Danesi R, Di Paulo A, Cupini S, Marcucci L, Pfanner E, Brunetti I, Conte P-F, Del Tacca M, Falcone A (2002) Bi-weekly irinotecan (CPT-11), oxaliplatin (LOHP), leucovorin (LV) and 5-fluorouracil (5-FU) 48 hrs. continuous infusion in advanced colorectal cancer (ACRC). Proc Am Soc Clin Oncol 21:169a

    Google Scholar 

  84. Ellis LM, Hoff PM (2004) Targeting the EGFR: an important incremental step in the battle against colorectal cancer. J Clin Oncol 22:1177–1179

    Article  PubMed  Google Scholar 

  85. Saltz LB, Meropol NJ, Joehrer RJ, Needle MN, Kopit J, Mayer R (2004) Phase II trial of cetuximab in patients with refractory colorectal cancer that express the EGFR. J Clin Oncol 22:1201–1208

    Article  PubMed  CAS  Google Scholar 

  86. Chung KY, Shia J, Kemney NE, Shah M, Schwartz GK, Tse A, Hamilton A, Pan D, Schrag D, Schwartz L, Klimstra DS, Fridman D, Kelsen D, Saltz LB (2005) Cetuximab shows activity in colorectal cancer patients with tumors that do not express the EGFR by immunohistochemistry. J Clin Oncol 23:1803–1809

    Article  PubMed  CAS  Google Scholar 

  87. Sparano JA, Gray R, Gianoti BO, Dwyer P, Comis RL (2004) Evaluating antiangiogenesis agents in the clinic: the eastern cooperative oncology group portfolio of clinical trial. Clin Cancer Res 10:1206–1211

    Article  PubMed  CAS  Google Scholar 

  88. Ashele C, Lonardi S, Monfardini S (2002) Thymidylate synthase expression as a predictor of the clinical response to fluoropyrimidive-based chemotherapy in advanced colorectal cancer. Treat Rev 28:27–47

    Article  CAS  Google Scholar 

  89. Loreng M, Resion I (1995) Adjuvant and palliative regional therapy of liver metastases in colorectal tumors. Dtsch Med Wochenschr 120:690–697

    Article  PubMed  Google Scholar 

  90. Benson AB (1998) Therapy for advanced colorectal cancer. Semin Oncol 25:2–11

    PubMed  CAS  Google Scholar 

  91. Kemeny MM, Adak S, Gay B, Macdonald JS, Smith T, Lpsitz S, Sigundson ER, Dwyer JO, Benson AB (2002) Combined modality treatment for respectable metastaic colorectal carcinoma to the liver. J Clin Oncol 20:1499–1505

    Article  PubMed  Google Scholar 

  92. Tanaka K, Adam R, Shimada H, Azouley D, Levi F, Bismuth H (2003) Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver. Br J Surg 90:963–969

    Article  PubMed  CAS  Google Scholar 

  93. Allen PF, Kemeny N, Jarnegin W, Dematteo R, Blumgardt L, Fong R (2003) Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal time metastases. J Gastrointest Surg 7:109–117

    Article  PubMed  Google Scholar 

  94. Cholett P, Amat S, Cure H, de Latour M, Le Bouedec G, Mouret-Reynier MA, Ferriere JP, Achard JL, Dauplat J, Penault-Llorca F. (2002) Prognostic significance of a complete pathological response after induction chemotherapy in operable breast cancer. Br J Cancer 86:1041–1046

    Article  PubMed  Google Scholar 

  95. Tabira Y, Yasunaga M, Sakaguchi T, Nagamoto N, Ogi S, Kitamura N (2000) Predicting initial recurrence pattern of esophageal cancer after neoadjuvant chemotherapy. Hepatogastroenterology 47:1315–1318

    PubMed  CAS  Google Scholar 

  96. Miyanari N, Mori T, Takahashi K, Yasuno M (2002) Evaluation of aggressively treated patients with unresectable multiple liver metastases from colorectal cancer. Dis Colon Rectum 45:1503–1509

    Article  PubMed  Google Scholar 

  97. Clavien PA, Selzner N, Morse M, Selzner M, Paulson E (2002) Downstaging of hepatocellular carcinoma and liver metastases from colorectal cancer by selective intra-arterial chemotherapy. Surgery 131:433–42

    Google Scholar 

  98. Catalano V, Baldelli AM, Giordani P, Cascinu S (2001) Molecular marker predictive of response to chemotherapy in gastrointestinal tumor. Crit Rev Oncol Hematol 38:93–104

    PubMed  CAS  Google Scholar 

  99. Ashele C, Debernardes D, Londardi S, Bandelloni R, Casezza S, Monfardini S, Gallo L (2004) Deleted colon cancer protein expression in colorectal cancer metastasis. J Clin Oncol 22:3758–3765

    Article  PubMed  CAS  Google Scholar 

  100. Tanaka T, Tanimoto K, Otani K, Satoh K, Ohtaka M, Yoshida K, Toge T, Yahata H, Tanada S, Chayama K, Okazaki Y, Hayashizaki Y, Hiyama K, Nishiyama M (2004) Concise prediction models of anticancer efficacy of 8 drugs using expression data from 12 selected genes. Int J Cancer 111:617–626

    Article  PubMed  CAS  Google Scholar 

  101. Ghadimi BM, Grade M, Di Filippantonio MJ, Varma S, Simon R, Montagner C, Fuzesi L, Langen C, Becker H, Liersch T, Ried T (2005) Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemotherapy. J Clin Oncol 23:1826–1838

    Article  PubMed  CAS  Google Scholar 

  102. Shrag D, Garewal HS, Burstein HF, Samson DJ, von Hoff DD, Mark R (2004) American society of clinical oncology technology assessment: chemotherapy sensitivity and resistance assay. J Clin Oncol 22:3631–3638

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan

    Hiroshi Shimada, Kuniya Tanaka, Kenichi Matsuo & Shinji Togo

Authors
  1. Hiroshi Shimada
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kuniya Tanaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kenichi Matsuo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shinji Togo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hiroshi Shimada.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shimada, H., Tanaka, K., Matsuo, K. et al. Treatment for multiple bilobar liver metastases of colorectal cancer. Langenbecks Arch Surg 391, 130–142 (2006). https://doi.org/10.1007/s00423-005-0003-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00423-005-0003-7

Keywords

Search

Navigation